These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29869263)

  • 1. Displaying Whole-Chain Proteins on Hepatitis B Virus Capsid-Like Particles.
    Heger-Stevic J; Kolb P; Walker A; Nassal M
    Methods Mol Biol; 2018; 1776():503-531. PubMed ID: 29869263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.
    Walker A; Skamel C; Vorreiter J; Nassal M
    J Biol Chem; 2008 Nov; 283(48):33508-15. PubMed ID: 18826949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.
    Nassal M; Skamel C; Vogel M; Kratz PA; Stehle T; Wallich R; Simon MM
    Int J Med Microbiol; 2008 Jan; 298(1-2):135-42. PubMed ID: 17888729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
    Kolb P; Wallich R; Nassal M
    PLoS One; 2015; 10(9):e0136180. PubMed ID: 26352137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency.
    Ravin NV; Blokhina EA; Kuprianov VV; Stepanova LA; Shaldjan AA; Kovaleva AA; Tsybalova LM; Skryabin KG
    Vaccine; 2015 Jun; 33(29):3392-7. PubMed ID: 25937448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins.
    Vogel M; Vorreiter J; Nassal M
    Proteins; 2005 Feb; 58(2):478-88. PubMed ID: 15526302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus core particles as epitope carriers.
    Pumpens P; Borisova GP; Crowther RA; Grens E
    Intervirology; 1995; 38(1-2):63-74. PubMed ID: 8666525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core particles of hepatitis B virus as carrier for foreign epitopes.
    Ulrich R; Nassal M; Meisel H; Krüger DH
    Adv Virus Res; 1998; 50():141-82. PubMed ID: 9520999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
    Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
    Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.
    Skamel C; Ploss M; Böttcher B; Stehle T; Wallich R; Simon MM; Nassal M
    J Biol Chem; 2006 Jun; 281(25):17474-17481. PubMed ID: 16621801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system.
    Newman M; Chua PK; Tang FM; Su PY; Shih C
    J Virol; 2009 Oct; 83(20):10616-26. PubMed ID: 19656897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
    Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
    Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.
    Blokhina EA; Kuprianov VV; Stepanova LA; Tsybalova LM; Kiselev OI; Ravin NV; Skryabin KG
    Virology; 2013 Jan; 435(2):293-300. PubMed ID: 23062739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
    Seifer M; Standring DN
    Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B core-based virus-like particles to present heterologous epitopes.
    Roose K; De Baets S; Schepens B; Saelens X
    Expert Rev Vaccines; 2013 Feb; 12(2):183-98. PubMed ID: 23414409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBcAg produced in transgenic tobacco triggers Th1 and Th2 response when intramuscularly delivered.
    Pyrski M; Rugowska A; Wierzbiński KR; Kasprzyk A; Bogusiewicz M; Bociąg P; Samardakiewicz S; Czyż M; Kurpisz M; Pniewski T
    Vaccine; 2017 Oct; 35(42):5714-5721. PubMed ID: 28917537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.